 The National Law Journal | India board rules against Bayer in cancer drug patent case Reuters Announcing the decision, Justice Prabha Sridevan said the kidney and liver cancer drug should be available at an affordable price to everybody. Bayer said in a statement it "strongly disagreed" with the conclusions of the board, adding that it would ... India Patent Ruling on Cancer Drug a Blow to Bayer AG India Appeals Body Rejects Bayer's Plea on Nexavar Bayer to Appeal India Ruling That Allows Copy of Cancer Drug |
